Author: admin

Disclaimer

This content is approved by Eli Lilly and company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly’s prior permission
For adverse events and safety reporting, please send an email: Saudi_Pharmacovigilance@lilly.com
For further information, please contact: Eli Lilly and Company, Scientific office O.O Box 92120
Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800
Please click here for Humalog Prescribing Information
Please click here for Trulicity Prescribing Information